Market Overview:
The global transcatheter devices market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in transcatheter devices, and rising demand for minimally invasive procedures. The global transcatheter devices market is segmented on the basis of type into TAVR (transcatheter aortic valve replacement), TAVI (transcatheter mitral valve replacement), TMVR (transcather mitral valve repair), and TMVI (transcather mitral valve intervention). The TAVR segment is expected to account for the largest share of the global transcatheter devices market in 2018. This segment is projected to grow at a CAGR of 11.5% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to increasing demand for minimally invasive procedures and technological advancements in TAVR products. On the basis of application, the global transcatheter devices market is divided into cardiovascular, oncology, neurology, urology, and others segments. The cardiovascular segment accounted for majority share of this market in 2017 and it is projected grow at a CAGR 9% duringthe forecast period from2018-2030 .
Product Definition:
Transcatheter devices are medical devices that are inserted into the body through a small opening, such as an artery or vein, to perform medical procedures. The most common type of transcatheter device is a stent, which is used to prop open blocked arteries. Other types of transcatheter devices include catheters and valves.
TAVR:
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure for replacing the damaged or diseased valve. The technology has evolved over time and currently, it’s being used in more than 100 countries with around 1 million procedures performed globally each year.
TAVI:
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure for the replacement of damaged or diseased valve. The treatment option is gaining popularity due to its several advantages such as reduced scarring, faster recovery time, and low risk of infection as compared to conventional surgical procedures. TAVR has been approved by the U.
Application Insights:
The others segment that includes oncology, neurology, and urology held the largest market share in 2017. This is due to the increasing prevalence of cancer and growing number of patients suffering from neurological disorders. According to WHO, it is estimated that approximately 14.1 million people died from cancer worldwide in 2018. The cardiovascular application segment is expected to witness lucrative growth over the forecast period owing to an increase in patient population suffering from heart-related diseases such as stroke and heart attack across all age groups globally.
According to a study published by NCBI in 2019, it was found that around 6% of U.S adults have at least one risk factor for cardiovascular disease (CVD).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing R&D activities are some of the major factors contributing to its growth. Moreover, growing target population base and rising incidences of CVDs & hypertension are expected to drive the regional market further.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and rising patient awareness regarding transcatheter valve replacement procedures along with technological advancements in valves manufacturing techniques.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) and other chronic diseases: The global prevalence of CVDs is estimated to be around 17.5% in 2010 and is projected to reach 23.6% by 2030. This will create a large pool of patients who will require treatment, thereby driving the demand for transcatheter devices.
- Technological advancements: The development of novel technologies and products has helped in expanding the application areas for transcatheter devices, thus driving market growth. For instance, the introduction of drug-eluting stents has revolutionized the treatment landscape for coronary artery disease (CAD).
- Rising geriatric population: With increasing life expectancy and declining fertility rates, the global geriatric population is growing at a rapid pace. This segment is highly susceptible to CVDs, which in turn is propelling demand for transcatheter devices worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcatheter Devices Market Research Report
By Type
TAVR, TAVI, TMVR, TMVI
By Application
Cardiovascular, Oncology, Neurology, Urology, Others
By Companies
Abbott Laboratories, Edwards Lifesciences, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd., Valcare Medical, CryoLife, Inc., JenaValve Technology, Inc., Terumo Medical Corporation, Meril Lifesciences Pvt. Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Transcatheter Devices Market Report Segments:
The global Transcatheter Devices market is segmented on the basis of:
Types
TAVR, TAVI, TMVR, TMVI
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Oncology, Neurology, Urology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Edwards Lifesciences
- Boston Scientific Corp.
- Medtronic Inc.
- Vascular Innovations Co. Ltd.
- Valcare Medical
- CryoLife, Inc.
- JenaValve Technology, Inc.
- Terumo Medical Corporation
- Meril Lifesciences Pvt. Ltd.
Highlights of The Transcatheter Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- TAVR
- TAVI
- TMVR
- TMVI
- By Application:
- Cardiovascular
- Oncology
- Neurology
- Urology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcatheter Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transcatheter device is a medical device that is inserted through the skin and used to deliver medications or other treatments directly to the inside of the body.
Some of the major players in the transcatheter devices market are Abbott Laboratories, Edwards Lifesciences, Boston Scientific Corp., Medtronic Inc., Vascular Innovations Co. Ltd., Valcare Medical, CryoLife, Inc., JenaValve Technology, Inc., Terumo Medical Corporation, Meril Lifesciences Pvt. Ltd..
The transcatheter devices market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcatheter Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcatheter Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcatheter Devices Market - Supply Chain
4.5. Global Transcatheter Devices Market Forecast
4.5.1. Transcatheter Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcatheter Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transcatheter Devices Market Absolute $ Opportunity
5. Global Transcatheter Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transcatheter Devices Market Size and Volume Forecast by Type
5.3.1. TAVR
5.3.2. TAVI
5.3.3. TMVR
5.3.4. TMVI
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transcatheter Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transcatheter Devices Market Size and Volume Forecast by Application
6.3.1. Cardiovascular
6.3.2. Oncology
6.3.3. Neurology
6.3.4. Urology
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transcatheter Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transcatheter Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transcatheter Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transcatheter Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transcatheter Devices Demand Share Forecast, 2019-2026
9. North America Transcatheter Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transcatheter Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transcatheter Devices Market Size and Volume Forecast by Application
9.4.1. Cardiovascular
9.4.2. Oncology
9.4.3. Neurology
9.4.4. Urology
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transcatheter Devices Market Size and Volume Forecast by Type
9.7.1. TAVR
9.7.2. TAVI
9.7.3. TMVR
9.7.4. TMVI
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transcatheter Devices Demand Share Forecast, 2019-2026
10. Latin America Transcatheter Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transcatheter Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transcatheter Devices Market Size and Volume Forecast by Application
10.4.1. Cardiovascular
10.4.2. Oncology
10.4.3. Neurology
10.4.4. Urology
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transcatheter Devices Market Size and Volume Forecast by Type
10.7.1. TAVR
10.7.2. TAVI
10.7.3. TMVR
10.7.4. TMVI
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transcatheter Devices Demand Share Forecast, 2019-2026
11. Europe Transcatheter Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transcatheter Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transcatheter Devices Market Size and Volume Forecast by Application
11.4.1. Cardiovascular
11.4.2. Oncology
11.4.3. Neurology
11.4.4. Urology
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transcatheter Devices Market Size and Volume Forecast by Type
11.7.1. TAVR
11.7.2. TAVI
11.7.3. TMVR
11.7.4. TMVI
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transcatheter Devices Demand Share, 2019-2026
12. Asia Pacific Transcatheter Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transcatheter Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transcatheter Devices Market Size and Volume Forecast by Application
12.4.1. Cardiovascular
12.4.2. Oncology
12.4.3. Neurology
12.4.4. Urology
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transcatheter Devices Market Size and Volume Forecast by Type
12.7.1. TAVR
12.7.2. TAVI
12.7.3. TMVR
12.7.4. TMVI
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transcatheter Devices Demand Share, 2019-2026
13. Middle East & Africa Transcatheter Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transcatheter Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transcatheter Devices Market Size and Volume Forecast by Application
13.4.1. Cardiovascular
13.4.2. Oncology
13.4.3. Neurology
13.4.4. Urology
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transcatheter Devices Market Size and Volume Forecast by Type
13.7.1. TAVR
13.7.2. TAVI
13.7.3. TMVR
13.7.4. TMVI
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transcatheter Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transcatheter Devices Market: Market Share Analysis
14.2. Transcatheter Devices Distributors and Customers
14.3. Transcatheter Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Edwards Lifesciences
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific Corp.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medtronic Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Vascular Innovations Co. Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Valcare Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CryoLife, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. JenaValve Technology, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Terumo Medical Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Meril Lifesciences Pvt. Ltd.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
